Efficacy and safety of tadalafil 5 mg once daily in the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia in men aged ≥75 years: integrated analyses of pooled data from multinational, randomized, placebo-controlled cli-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and safety of tadalafil 5 mg once daily in the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia in men aged ≥75 years: integrated analyses of pooled data from multinational, randomized, placebo-controlled cli

Published:2017-01-22 Issue:5 Volume:119 Page:793-803
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Oelke Matthias¹,Wagg Adrian²,Takita Yasushi³,Büttner Hartwig⁴,Viktrup Lars⁵

Affiliation:

1. Department of Urology; Hannover Medical School; Hannover Germany

2. Geriatric Medicine; University of Alberta; Edmonton AB Canada

3. Medicines Development Unit Japan; Eli Lilly Japan; Kobe Hyogo Japan

4. Eli Lilly Biomedicines BU - Men's Health Therapeutic Area Europe; c/o Lilly Deutschland, GmbH; Bad Homburg Germany

5. Lilly Research Laboratories; Eli Lilly and Company; Indianapolis IN USA

Funder

Eli Lilly and Company

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.13744/fullpdf

Reference31 articles.

1. Prevalence of lower urinary tract symptoms and effect on quality of life in a racially and ethnically diverse random sample: the Boston Area Community Health (BACH) Survey;Kupelian;Arch Intern Med,2006

2. Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7);Rosen;Eur Urol,2003

3. Coexisting lower urinary tract symptoms and erectile dysfunction: a systematic review of epidemiological data;Seftel;Int J Clin Pract,2013

4. Appropriateness of oral drugs for long-term treatment of lower urinary tract symptoms in older persons: results of a systematic literature review and international consensus validation process (LUTS-FORTA 2014);Oelke;Age Ageing,2015

5. Efficacy and safety of tadalafil 5mg once daily for lower urinary tract symptoms suggestive of benign prostatic hyperplasia: subgroup analyses of pooled data from 4 multinational, randomized, placebo-controlled clinical studies;Porst;Urology,2013

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risks and side effects in the medical management of benign prostatic hyperplasia;Prostate International;2023-12

2. Treating LUTS in Men with Benign Prostatic Obstruction: A Review Article;Drugs & Aging;2023-08-09

3. The Geriatric Patient;Benign Prostate Syndrome;2023

4. Lower urinary tract symptoms (LUTS): The role of medications in improvement of quality of life;Galenika Medical Journal;2022

5. Der geriatrische Patient;Benignes Prostatasyndrom;2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3